학술논문

Long non‐coding RNA ESCCAL‐1/miR‐590/LRP6 signaling pathway participates in the progression of esophageal squamous cell carcinoma
Document Type
article
Source
Cancer Medicine. 12(1)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Cancer
Biotechnology
Digestive Diseases
Aetiology
2.1 Biological and endogenous factors
Humans
Esophageal Squamous Cell Carcinoma
RNA
Long Noncoding
Esophageal Neoplasms
MicroRNAs
Signal Transduction
Cell Proliferation
Cell Line
Tumor
Cell Movement
Gene Expression Regulation
Neoplastic
Low Density Lipoprotein Receptor-Related Protein-6
EMT
ESCC
ESCCAL-1
miR-590
LRP6
Biochemistry and Cell Biology
Oncology and carcinogenesis
Language
Abstract
BackgroundLong non-coding RNAs (lncRNAs) have critical functions within esophageal squamous cell carcinoma (ESCC). However, the function and mechanism underlying ESCC-associated lncRNA-1 (ESCCAL-1) in ESCC tumorigenesis have not been well clarified.MethodsESCCAL-1, miR-590 and LRP6 were quantified using qRT-PCR. Cell viability, migration and invasion abilities were measured using CCK-8 assay and transwell assays. The protein pression was determined with western blot assay. The xenograft model assays were used to examine the impact of ESCCAL-1 on tumorigenic effect in vivo. Direct relationships among ESCCAL-1, miR-590 and LRP6 were confirmed using dual-luciferase reporter assays.ResultsThe present work discovered the ESCCAL-1 up-regulation within ESCC. Furthermore, ESCCAL-1 was found to interact with miR-590 and consequently restrict its expression. Functionally, knocking down ESCCAL-1 or over-expressing miR-590 hindered ESCC cell growth, invasion, and migration in vitro. Moreover, inhibition of miR-590 could reverse the effect of knockdown of ESCCAL-1 on cells. Importantly, it was confirmed that LRP6 was miR-590's downstream target and LRP6 over-expression also partly abolished the role of miR-590 overexpression in ESCC cells.ConclusionWe have uncovered a novel regulatory network comprising aberrant interaction of ESCCAL-1/miR-590/LRP6 participated in ESCC progression.